The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Bevacizumab, TAS-102, and irinotecan in oxaliplatin and fluoropyrimidine pre-treated metastatic colorectal cancer (BEV-TASIRI): A single-arm, prospective, multicenter study and comparison with BEV-FOLFIRI/XELIRI using inverse probability of treatment weighting.
 
Xiangling Wang
No Relationships to Disclose
 
Jian Wang
No Relationships to Disclose
 
Cuihua Yi
No Relationships to Disclose
 
Wenfei Han
No Relationships to Disclose
 
Yawei Wang
No Relationships to Disclose
 
Linli Qu
No Relationships to Disclose
 
Jian Chen
No Relationships to Disclose
 
Jing Lv
No Relationships to Disclose
 
Yong Cui
No Relationships to Disclose
 
Mianli Li
No Relationships to Disclose
 
Feng Wang
No Relationships to Disclose
 
Xiaorong Yang
No Relationships to Disclose
 
Jing Hao
No Relationships to Disclose